A Seattle-based nonprofit launched to provide digital health solutions for poorer countries is applying its expertise to help with COVID-19 testing.
Audere is building software for administering rapid result COVID tests that can be integrated into products being developed by U.S. manufacturers that use saliva or nasal swab samples.
“There is a critical need for rapid testing,” said Philip Su, CEO and founder of Audere. People are increasingly realizing that the widespread distribution of a vaccine is still many months away. The availability of accurate, inexpensive tests that provide results in minutes can help control the spread of the virus in the meantime, Su said.
The tests — known generally as rapid diagnostic tests or RDTs — can have high rates of failure, though the basic concept is simple. Imagine